![]()
|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Papers In Press, published online ahead of print September 30, 2002
Department of Medicine, St George Clinical School, Sydney, NSW 2052
Corresponding Author: b.h.chong{at}unsw.edu.au
The exposure of collagen fibres at sites of vascular injury results in the adherence of platelets and their subsequent activation. The platelet collagen receptor glycoprotein (GP) VI plays a crucial role in platelet activation and thrombus formation and decreased levels or defective GPVI may lead to excessive bleeding. In addition, elevated levels of collagen receptors may predispose individuals to coronary heart disease or strokes. GPVI expression is restricted to platelets and their precursor cell, the megakaryocyte (MK). In this study we investigate the regulation of GPVI expression and show that thrombopoietin (TPO) induces its expression in the megakaryocytic cell line UT-7/TPO. A 5'-region flanking the transcription start point of the GPVI gene was cloned (-694 to +29) and we report that this putative GPVI promoter bestows MK specific expression. Deletion analyses and site directed mutagenesis identified Sp1227, GATA177 and Ets48 sites as essential for GPVI expression. We show that transcription factors GATA-1, Fli-1 and Sp1 can bind to and activate this promoter. Finally, GPVI mRNA was detected only in megakaryocytic cell lines expressing both Fli-1 and GATA-1, and we show that over-expression of Fli-1 in a stable cell line (which expresses endogenous GATA-1 and Sp1) results in expression of the endogenous GPVI gene.
J. Biol. Chem, 10.1074/jbc.M206127200
Submitted on June 20, 2002
Revised on September 6, 2002
Accepted on September 30, 2002
Cloning and analysis of the thrombopoietin-induced megakaryocyte-specific glycoprotein VI promoter and its regulation by GATA-1, Fli-1 and Sp1
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
T. Sawada, C. Nishiyama, T. Kishi, T. Sasazuki, S. Komazawa-Sakon, X. Xue, J.-H. Piao, H. Ogata, J.-i. Nakayama, T. Taki, et al. Fusion of OTT to BSAC Results in Aberrant Up-regulation of Transcriptional Activity J. Biol. Chem., September 26, 2008; 283(39): 26820 - 26828. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Hazony, J. Lu, C. St. Hilaire, and K. Ravid Hematopoietic gene promoters subjected to a group-combinatorial study of DNA samples: identification of a megakaryocytic selective DNA signature Nucleic Acids Res., September 11, 2006; 34(16): 4416 - 4428. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ohmori, J. Mimuro, K. Takano, S. Madoiwa, Y. Kashiwakura, A. Ishiwata, M. Niimura, K. Mitomo, T. Tabata, M. Hasegawa, et al. Efficient expression of a transgene in platelets using simian immunodeficiency virus-based vector harboring glycoprotein Ib{alpha} promoter: in vivo model for platelet-targeting gene therapy FASEB J, July 1, 2006; 20(9): 1522 - 1524. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Fang, K. Hodivala-Dilke, B. D. Johnson, L. M. Du, R. O. Hynes, G. C. White II, and D. A. Wilcox Therapeutic expression of the platelet-specific integrin, {alpha}IIb{beta}3, in a murine model for Glanzmann thrombasthenia Blood, October 15, 2005; 106(8): 2671 - 2679. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Hughan, Y. Senis, D. Best, A. Thomas, J. Frampton, P. Vyas, and S. P. Watson Selective impairment of platelet activation to collagen in the absence of GATA1 Blood, June 1, 2005; 105(11): 4369 - 4376. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kanaji, T. Kanaji, B. Jacquelin, M. Chang, D. J. Nugent, N. Komatsu, M. Moroi, K. Izuhara, and T. J. Kunicki Thrombopoietin initiates demethylation-based transcription of GP6 during megakaryocyte differentiation Blood, May 15, 2005; 105(10): 3888 - 3892. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Hu, A. S. Philips, J. C. Kwok, M. Eisbacher, and B. H. Chong Identification of Nuclear Import and Export Signals within Fli-1: Roles of the Nuclear Import Signals in Fli-1-Dependent Activation of Megakaryocyte-Specific Promoters Mol. Cell. Biol., April 15, 2005; 25(8): 3087 - 3108. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Masuya, O. Moussa, T. Abe, T. Deguchi, T. Higuchi, Y. Ebihara, D. D. Spyropoulos, D. K. Watson, and M. Ogawa Dysregulation of granulocyte, erythrocyte, and NK cell lineages in Fli-1 gene-targeted mice Blood, January 1, 2005; 105(1): 95 - 102. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Jackers, G. Szalai, O. Moussa, and D. K. Watson Ets-dependent Regulation of Target Gene Expression during Megakaryopoiesis J. Biol. Chem., December 10, 2004; 279(50): 52183 - 52190. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Gottgens, C. Broccardo, M.-J. Sanchez, S. Deveaux, G. Murphy, J. R. Gothert, E. Kotsopoulou, S. Kinston, L. Delaney, S. Piltz, et al. The scl +18/19 Stem Cell Enhancer Is Not Required for Hematopoiesis: Identification of a 5' Bifunctional Hematopoietic-Endothelial Enhancer Bound by Fli-1 and Elf-1 Mol. Cell. Biol., March 1, 2004; 24(5): 1870 - 1883. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |